
Metformin (500mg)
Active composition
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Metsmall 500 Tablet SR is a delayed-release oral medication containing Metformin 500mg, a biguanide antidiabetic agent. It is indicated for the treatment of type 2 diabetes mellitus, particularly in patients who are intolerant to sulfonylureas or as an adjunct to diet and exercise to improve glycemic control. Metsmall 500 Tablet SR works by reducing the amount of glucose produced by the liver and increasing the body's sensitivity to insulin, thereby improving glucose tolerance. The sustained-release formulation provides a steady release of Metformin over 24 hours, allowing for once-daily dosing. Metsmall 500 Tablet SR is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or those with impaired kidney function or liver disease. Common side effects include gastrointestinal disturbances, metallic taste, and headache. Metsmall 500 Tablet SR is available in a standardized formulation and should be taken as directed by a healthcare provider.
Biguanides Derivative
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Metsmall 500 Tablet SR is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
High Risk
Metsmall 500 Tablet SR should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Medical Advice
Metsmall 500 Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Metsmall 500 Tablet SR may be needed. Please consult your doctor. Use of Metsmall 500 Tablet SR is, however, not recommended in patients with severe kidney disease.
Exercise Caution
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Metsmall 500 Tablet SR is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Metsmall 500 Tablet SR may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Metsmall 500 Tablet SR

Metformin (500mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
Metsmall 500 Tablet SR is a delayed-release oral medication containing Metformin 500mg, a biguanide antidiabetic agent. It is indicated for the treatment of type 2 diabetes mellitus, particularly in patients who are intolerant to sulfonylureas or as an adjunct to diet and exercise to improve glycemic control. Metsmall 500 Tablet SR works by reducing the amount of glucose produced by the liver and increasing the body's sensitivity to insulin, thereby improving glucose tolerance. The sustained-release formulation provides a steady release of Metformin over 24 hours, allowing for once-daily dosing. Metsmall 500 Tablet SR is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or those with impaired kidney function or liver disease. Common side effects include gastrointestinal disturbances, metallic taste, and headache. Metsmall 500 Tablet SR is available in a standardized formulation and should be taken as directed by a healthcare provider.
Biguanides Derivative
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Metsmall 500 Tablet SR is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
High Risk
Metsmall 500 Tablet SR should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Medical Advice
Metsmall 500 Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Metsmall 500 Tablet SR may be needed. Please consult your doctor. Use of Metsmall 500 Tablet SR is, however, not recommended in patients with severe kidney disease.
Exercise Caution
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Consult Doctor
Metsmall 500 Tablet SR is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Metsmall 500 Tablet SR may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Metsmall 500 Tablet SR













